Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Eidos Therapeutics Inc (EIDX)

Eidos Therapeutics Inc (EIDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,750,670
  • Shares Outstanding, K 38,873
  • Annual Sales, $ 26,690 K
  • Annual Income, $ -37,840 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta -0.16
  • Price/Sales 36,543.62
  • Price/Cash Flow N/A
  • Price/Book 38.46
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.65
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 02/24/21
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.77
  • Number of Estimates 3
  • High Estimate -0.74
  • Low Estimate -0.81
  • Prior Year -0.51
  • Growth Rate Est. (year over year) -50.98%

Price Performance

See More
Period Period Low Period High Performance
1-Month
116.24 +5.14%
on 01/05/21
132.54 -7.79%
on 01/04/21
-5.49 (-4.30%)
since 12/24/20
3-Month
69.38 +76.16%
on 10/30/20
132.54 -7.79%
on 01/04/21
+48.92 (+66.75%)
since 10/23/20
52-Week
28.39 +330.47%
on 03/16/20
132.54 -7.79%
on 01/04/21
+68.05 (+125.65%)
since 01/24/20

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Eidos Therapeutics, Inc. is a clinical stage biopharmaceutical company. It discovers and develops novel oral therapy for the treatment of diseases caused by transthyretin amyloidosis. Eidos Therapeutics, Inc. is based in San Francisco, United States.

See More

Key Turning Points

3rd Resistance Point 139.85
2nd Resistance Point 134.17
1st Resistance Point 128.19
Last Price 122.21
1st Support Level 116.53
2nd Support Level 110.85
3rd Support Level 104.87

See More

52-Week High 132.54
Last Price 122.21
Fibonacci 61.8% 92.75
Fibonacci 50% 80.46
Fibonacci 38.2% 68.18
52-Week Low 28.39

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar